tumor, solid
Showing 1 - 25 of 41
Tumor, Solid Trial in Nanchong (Radiation: 18F-AlF-FAPi-04, Radiation: 18F-FDG)
Recruiting
- Tumor, Solid
- Radiation: 18F-AlF-FAPi-04
- Radiation: 18F-FDG
-
Nanchong, Sichuan, ChinaAffiliated Hospital of North Sichuan Medical College
Nov 6, 2023
Immune Profiling for Cancer Immunotherapy Response
Recruiting
- Cancer
- +3 more
- Methylation Cytometry
-
Lebanon, New HampshireDartmouth-Hitchcock Medical Center
Nov 6, 2023
Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (ONM-501, Cemiplimab)
Not yet recruiting
- Triple Negative Breast Cancer
- +13 more
- (no location specified)
Aug 29, 2023
Tumor, Solid Trial in Caen, Lille (RCMI in painting dose on histoscannographic mapping, Standard pan-sinusal IMRT)
Not yet recruiting
- Tumor, Solid
- RCMI in painting dose on histoscannographic mapping
- Standard pan-sinusal IMRT
-
Caen, France
- +2 more
Jul 5, 2023
Renal Cancer, Tumor, Solid, Kidney Cancer Trial (HistoSonics Edison System)
Not yet recruiting
- Renal Cancer
- +4 more
- HistoSonics Edison System
- (no location specified)
Apr 18, 2023
Biomarkers of Renal Cancer
Recruiting
- Renal Cell Carcinoma
- +3 more
-
Firenze, Italy
- +3 more
Mar 14, 2023
Cancer Pain, Tumor, Solid, Carcinoma Trial in Xinxiang (PCA pump)
Not yet recruiting
- Cancer Pain
- +2 more
- PCA pump
-
Xinxiang, Henan, ChinaThe First Affiliated Hospital of Xinxiang Medical University
Feb 24, 2023
Cancer, Tumor, Solid, Advanced Solid Tumor Trial in Houston (NTX-1088, Pembrolizumab)
Recruiting
- Cancer
- +4 more
-
Houston, TexasThe University of Texas MD Anderson Cancer Center
Jan 24, 2023
Tumor, Solid Trial (Indocyanine Green)
Not yet recruiting
- Tumor, Solid
- Indocyanine Green
- (no location specified)
Jan 24, 2023
Tumor, Solid, Gastrointestinal Cancer Trial in San Francisco, Ann Arbor (Ulixertinib, Hydroxychloroquine)
Recruiting
- Tumor, Solid
- Gastrointestinal Cancer
-
Tucson, Arizona
- +7 more
Jan 13, 2023
Tumor, Solid Trial in Beijing (68Ga-DOTA-F2 PET/CT and 18F-FDG)
Recruiting
- Tumor, Solid
- 68Ga-DOTA-F2 PET/CT and 18F-FDG
-
Beijing, Beijing, ChinaPeking union medical college hospital
Nov 27, 2022
Tumor, Solid, Pancreatic Cancer Trial in Chapel Hill (Ulixertinib, Palbociclib)
Recruiting
- Tumor, Solid
- +2 more
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center
Nov 30, 2022
Real-time Tumor Localization and Guidance for Radiotherapy Using
Recruiting
- Tumor, Solid
- 4D Planar US Transducer
-
Madison, WisconsinUniversity of Wisconsin, Madison
Nov 8, 2022
Tumor Rebiopsy in Children and Recurrent or Progressive Solid
Active, not recruiting
- Tumor, Solid
- Re-biopsy
- Questionnaire
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 10, 2022
Tumor, Solid, Positron-Emission Tomography Trial in Xiamen (18F-FDG PET/CT, 68Ga-FAPI-RGD PET/CT)
Recruiting
- Tumor, Solid
- Positron-Emission Tomography
- 18F-FDG PET/CT, 68Ga-FAPI-RGD PET/CT
-
Xiamen, Fujian, ChinaThe First Affiliated Hospital of Xiamen University
Sep 16, 2022
Tumor, Solid, Positron-Emission Tomography Trial in Xiamen (18F-FDG)
Recruiting
- Tumor, Solid
- Positron-Emission Tomography
- 18F-FDG
-
Xiamen, Fujian, ChinaThe First affiliated hospital of xiamen university
Aug 8, 2022
Renal Cancer, Tumor, Solid, Kidney Cancer Trial (HistoSonics System)
Not yet recruiting
- Renal Cancer
- +4 more
- HistoSonics System
- (no location specified)
Jul 26, 2022